PROTOCOL NIDA-CTN-0074


Primary Care Opioid Use Disorders (PROUD) Treatment Trial

Katharine Bradley, MD, MPH
Lead Investigator

Group Health Research Institute
bradley.k@ghc.org

Though treatment for opioid use disoders with medications (buprenorphine or naltrexone provided in primary care, or methadone from an Opioid Treatment Program) has been shown to be effective, the majority of patients with OUDs are never treated with medications, and most primary care practices do not offer buprenorphine treatment. This trial seeks to compare a collaborative care model to usual primary care for management of OUDs in primary care across multiple health care systems.

RELATED RESOURCES

snowflake

Publications about CTN-0074

NIDA protocol page

 


NODES & CTPs SEARCH LINK
Health Systems (Lead) search www
Group Health Cooperative
Henry Ford Health System
Kaiser-Permanente (Colorado, Northern California, Southern California, Northwest)
Florida Node Alliance search www
University of Miami Health System  
Greater New York search www
Montefiore Health System
Northstar search www
HealthPartners  
Pacific Northwest search www
MultiCare Health System
Texas search www
Harris Health System

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 6/2017 -- http://ctndisseminationlibrary.org/protocols/ctn0074.htm
info@ctndisseminationlibrary.org